Implications of reconstruction protocol for histo-biological characterisation of breast cancers using FDG-PET radiomics by Nicolas Aide, Thibault Salomon, Cécile Blanc-Fournier, Jean-Michel Grellard, Christelle Levy, Charline Lasnon

“…Procedures Forty-seven patients referred for breast cancer staging in the framework of a prospective study were reviewed as part of an ancillary study. …”
Get full text

Respiratory motion correction in F-18-FDG PET/CT impacts lymph node assessment in lung cancer patients by Benjamin Noto, Wolfgang Roll, Laura Zinken, Robert Rischen, Laura Kerschke, Georg Evers, Walter Heindel, Michael Schäfers, Florian Büther

Get full text

Dissemination of endometrial cancer MRI staging guidelines among young radiologists: an ESUR Junior Network survey by Arnaldo Stanzione, Eduardo Alvarez Hornia, Ana Sofia Linhares Moreira, Luca Russo, Pamela Causa Andrieu, Carlos Carnelli, Renato Cuocolo, Giorgio Brembilla, Jeries Paolo Zawaideh, for the ESUR Junior Network Committee

Get full text

The Rationality to Requesting in-ward Magnetic Resonance Imaging Investigation by Vahid Kermanian, Abdolmajid Taheri, Elham Raeisi, Mathias Hossain Aazami, Mohamad-Ali Dayani, Daryoush Shahbazi-Gahrouei

“…After excluding cancer diagnosis, cancer staging, and therapeutic follow-up exams, MRI request was oriented in 64.3% and 77.2% of positive results was concordant with aforementioned diagnostic orientation (P<0.001). …”
Get full text

Pathway-based classification of cancer subtypes by Kim Shinuk, Kon Mark, DeLisi Charles

“…</p> <p>Conclusions</p> <p>Standardizing the analysis of genomic data in the process of cancer staging, classification and analysis is important as it has implications for both pre-clinical as well as clinical studies. …”
Get full text

ABCG2/V-ATPase was associated with the drug resistance and tumor metastasis of esophageal squamous cancer cells by Huang Lijun, Lu Qiang, Han Yong, Li Zhe, Zhang Zhipei, Li Xiaofei

“…The TNM Classification of Malignant Tumours (TNM) is a cancer staging system that describes the extent of cancer in a patient’s body. …”
Get full text

The Role of Multiparametric MRI in the Local Staging of Prostate Cancer by Tiago Oliveira, Luís Amaral Ferreira, Carlos Miguel Marto, Cristina Marques, Carlos Oliveira, Paulo Donato

“…This review aims to highlight the significance of mpMRI in prostate cancer staging and provide a practical approach to assessing extracapsular extension, seminal vesicle invasions, and the involvement of adjacent organs and lymph nodes.…”
Get full text

The Diagnostic Efficiency of the Use of Non-Standard Surgical Instruments in Mediastinoscopy by Kemal Karapınar, Merve Özbek, Yunus Seyrek, Cemal Aker, Ali Murat Akçıl, Levent Cansever, Mehmet Ali Bedirhan

“…Introduction:Mediastinoscopy is an effective diagnostic method used in the diagnosing of benign granulomatous diseases and for lung cancer staging. However, the success of this method is directly proportional to the amount of pathological material taken. …”
Get full text

Real-World Recurrence Rates and Economic Burden in Patients with Resected Early-Stage Melanoma by Sekwon Jang, Tayla Poretta, Tarun Bhagnani, Qing Harshaw, Matthew Burke, Sumati Rao

“…Methods This retrospective analysis included patients with resected stage IIB, IIC, or IIIA melanoma (American Joint Committee on Cancer staging manual, seventh edition) in the Surveillance, Epidemiology, and End Results (SEER) program–Medicare database of the National Cancer Institute. …”
Get full text

Transcatheter arterial chemoembolization of hepatocellular carcinoma on liver cirrhosis in patients awaiting liver transplantation by A. S. Polekhin, T. P. Gadelgaraevich, I. I. Tileubergenov, I. O. Rutkin, D. A. Granov

“…According to the BCLC (Barcelona Clinic Liver Cancer) staging system, 10 patients matched A1–A4 stage and 6 – B stage. …”
Get full text

Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker by Pan Xie, Pan Xie, Jun-Yan Liu, Han Yan, Zhi-Bin Wang, Zhi-Bin Wang, Shi-Long Jiang, Shi-Long Jiang, Xi Li, Xi Li, Zhao-Qian Liu, Zhao-Qian Liu

“…In this study, we systematically analyzed the influence of DCBLD2 on prognosis, cancer staging, immune characteristics, and drug sensitivity in a variety of cancers based on a unified and standardized pan-cancer dataset. …”
Get full text

Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy endocrine therapy alone in patients with HR+/HER2− early breast cancer by Dennis J. Slamon, Peter A. Fasching, Sara Hurvitz, Stephen Chia, John Crown, Miguel Martín, Carlos H. Barrios, Aditya Bardia, Seock-Ah Im, Denise A. Yardley, Michael Untch, Chiun-Sheng Huang, Daniil Stroyakovskiy, Binghe Xu, Rebecca L. Moroose, Sherene Loi, Frances Visco, Valerie Bee-Munteanu, Karen Afenjar, Rodrigo Fresco, Tetiana Taran, Arunava Chakravartty, Juan Pablo Zarate, Agnes Lteif, Gabriel N. Hortobagyi

“…Select patients with stage IIA, stage IIB, or stage III disease (per the anatomic classification in the AJCC Cancer Staging Manual , 8th edition) with an initial diagnosis ⩽18 months prior to randomization are eligible. …”
Get full text

Advancing Korean nationwide registry for hepatocellular carcinoma: a systematic sampling approach utilizing the Korea Central Cancer Registry database by Bo Hyun Kim, E Hwa Yun, Jeong-Hoon Lee, Geun Hong, Jun Yong Park, Ju Hyun Shim, Eunyang Kim, Hyun-Joo Kong, Kyu-Won Jung, Young-Suk Lim

“…However, detailed information on cancer staging, specific characteristics, and treatments is lacking. …”
Get full text

Anti-Müllerian Hormone Type II Receptor Expression in Endometrial Cancer Tissue by Marek Gowkielewicz, Aleksandra Lipka, Marta Majewska, Aleksandra Piotrowska, Marta Szadurska-Noga, Jacek J. Nowakowski, Marta Wiszpolska, Piotr Dzięgiel, Tomasz Wasniewski, Mariusz Krzysztof Majewski, Marcin Jozwik

“…No statistical difference was observed for AMHRII expression depending on the histopathological type of EC, cancer staging, body mass index, and age, as well as the number of years of menstruation, births and miscarriages, and average and total breastfeeding time. …”
Get full text

Pericardial Window Operation in Oncology Patients: Analysis of Long-Term Survival and Prognostic Factors by Sung Min Kim, Jun Ho Lee, Su Ryeun Chung, Kiick Sung, Wook Sung Kim, Yang Hyun Cho

“…Multivariate analysis identified New York Heart Association class, cancer stage, and cytopathology as independent prognostic factors. …”

The transcriptional risk scores for kidney renal clear cell carcinoma using XGBoost and multiple omics data by Xiaoyu Hou, Baoshan Ma, Ming Liu, Yuxuan Zhao, Bingjie Chai, Jianqiao Pan, Pengcheng Wang, Di Li, Shuxin Liu, Fengju Song

“…The KM curves showed that TRS was a valid prognostic indicator for cancer staging. Our proposed method extended the current definition of TRS from standalone SNP data to multi-omics data and was superior to the linear models and other machine learning models, which may provide a useful implement for diagnostic and prognostic prediction of KIRC.…”
Get full text

Whole-Body MRI for the Detection of Recurrence in Melanoma Patients at High Risk of Relapse by Yanina J. L. Jansen, Inneke Willekens, Teofila Seremet, Gil Awada, Julia Katharina Schwarze, Johan De Mey, Carola Brussaard, Bart Neyns

“…<i>Material and Methods:</i> Patients with American Joint Committee on Cancer Staging Manual (seventh edition; AJCC-7) stages IIIb/c or -IV melanoma who were disease-free following resection of macrometastases (cohort A), or obtained a durable complete response (CR) or partial response (PR) following systemic therapy (cohort B), were included. …”
Get full text

Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage NSCLC by Jay M. Lee, MD, Rongrong Wang, MPH, Ann Johnson, MMSc, Sarika Ogale, PhD, Matthew Kent, MS, Janet S. Lee, PharmD, PhD

“…Patients were matched (1:1) using exact matching on cancer stage and treatment, and propensity score matching on other characteristics. …”
Get full text

Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in prostate cancer men by Kritika Subramanian, Juana Martinez, Sandra Huicochea Castellanos, Jana Ivanidze, Himanshu Nagar, Sean Nicholson, Trisha Youn, Jones T. Nauseef, Scott Tagawa, Joseph R. Osborne

“…The cost-effectiveness analysis demonstrated that [18F]DCFPyL PET/CT should be considered as an alternative to anti-3-[18F]FACBC PET/CT and standard of care imaging for prostate cancer staging. [18F]DCFPyL PET/CT is a new imaging modality to evaluate PC patients with higher sensitivity and specificity in detecting disease than other prostate specific imaging studies. …”
Get full text

Radiomics and Prostate MRI: Current Role and Future Applications by Giuseppe Cutaia, Giuseppe La Tona, Albert Comelli, Federica Vernuccio, Francesco Agnello, Cesare Gagliardo, Leonardo Salvaggio, Natale Quartuccio, Letterio Sturiale, Alessandro Stefano, Mauro Calamia, Gaspare Arnone, Massimo Midiri, Giuseppe Salvaggio

“…However, the traditional role of mpMRI was confined to prostate cancer staging. Radiomics is the quantitative extraction and analysis of minable data from medical images; it is emerging as a promising tool to detect and categorize prostate lesions. …”
Get full text